Pharming (PHAR) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$17.5 million.
- Pharming's Other Gross PP&E Adjustments rose 2028.67% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year increase of 2028.67%. This contributed to the annual value of -$16.4 million for FY2024, which is 3110.15% up from last year.
- Latest data reveals that Pharming reported Other Gross PP&E Adjustments of -$17.5 million as of Q3 2025, which was up 2028.67% from -$16.6 million recorded in Q2 2025.
- Over the past 5 years, Pharming's Other Gross PP&E Adjustments peaked at -$9067.3 during Q1 2021, and registered a low of -$30.4 million during Q1 2023.
- For the 5-year period, Pharming's Other Gross PP&E Adjustments averaged around -$18.7 million, with its median value being -$21.3 million (2021).
- Within the past 5 years, the most significant YoY rise in Pharming's Other Gross PP&E Adjustments was 9992.04% (2022), while the steepest drop was 21420911.44% (2022).
- Pharming's Other Gross PP&E Adjustments (Quarter) stood at -$20129.3 in 2021, then crashed by 142741.42% to -$28.8 million in 2022, then grew by 17.31% to -$23.8 million in 2023, then surged by 31.1% to -$16.4 million in 2024, then dropped by 6.93% to -$17.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$17.5 million in Q3 2025, compared to -$16.6 million in Q2 2025 and -$16.5 million in Q1 2025.